British Journal of Anaesthesia, 2003, Vol. 90, No. 2 122-126
© 2003 The Board of Management and Trustees of the British Journal of Anaesthesia
Clinical Investigations |
Plasma propofol concentration and EEG burst suppression ratio during normothermic cardiopulmonary bypass
Department of Anaesthesiology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan
Corresponding author. E-mail: nkenji@mva.biglobe.ne.jp 
This article is accompanied by Editorial II.
Background. During cardiopulmonary bypass (CPB), several factors affect drug disposition and action. This topic has not been studied extensively during normothermic CPB. In this study, we related propofol dose to plasma propofol concentration and burst suppression of the EEG during normothermic bypass.
Methods. After institutional approval and informed consent, 45 patients having cardiac surgery were assigned randomly to receive propofol infusions at 4 (Group A), 5 (Group B) and 6 (Group C) mg kg–1 h–1 during normothermic CPB. In all patients, small to moderate doses of fentanyl were also administered. Plasma propofol concentration and burst suppression ratio (BSR) were measured at the following times: (1) 10 min before CPB, (2) 10 min after the start of CPB, (3) 30 min after the start of the CPB, (4) just after aortic declamping, and (5) 60 min after CPB.
Results. At baseline, plasma propofol concentrations were similar among the three groups. After the start of CPB, the concentrations of propofol decreased significantly by 41, 35, and 30% of control values in Groups A, B, and C, respectively. In Group A, the concentration of propofol during CPB remained unchanged at less than the concentration before bypass. In Groups B and C, plasma propofol concentrations gradually increased during CPB to the pre-bypass concentrations. In Group A, BSR values did not change significantly during CPB. In Groups B and C, BSR values gradually increased and became significantly greater than baseline values. No patient reported intraoperative awareness.
Conclusion. The pharmacokinetics and pharmacodynamics of propofol change during normothermic CPB. During normothermic CPB, the efficacy of propofol may be enhanced compared with before CPB.
Br J Anaesth 2003; 90: 122–6
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J C Murrell, D Waters, and C B Johnson Comparative effects of halothane, isoflurane, sevoflurane and desflurane on the electroencephalogram of the rat Lab Anim, April 1, 2008; 42(2): 161 - 170. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Takizawa, H. Hiraoka, D. Takizawa, and F. Goto Changes in the effect of propofol in response to altered plasma protein binding during normothermic cardiopulmonary bypass Br. J. Anaesth., February 1, 2006; 96(2): 179 - 185. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. H. H. Lim, A. P. Halestrap, G. D. Angelini, and M.-S. Suleiman Propofol Is Cardioprotective in a Clinically Relevant Model of Normothermic Blood Cardioplegic Arrest and Cardiopulmonary Bypass Experimental Biology and Medicine, June 1, 2005; 230(6): 413 - 420. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. R. D. Marks Editorial II: Which anaesthetic agent for maintenance during normothermic cardiopulmonary bypass? Br. J. Anaesth., February 1, 2003; 90(2): 118 - 121. [Full Text] [PDF]
|
|